Table 1.

Demographic information of all included patients and patients included for subanalysis of histologic effects of dupilumab

Characteristics	All included patients (n = 12)	Patients included for subanalysis (n = 8)
Male, n (%)	7 (58.3)	6 (75)
Age, median (min–max, Q1–Q3)	37.1 (25.4–58.1, 33.5–44.4)	35.5 (25.4–44.1, 31.9–39.5)
Pediatric, n (%)	0 (0)	0 (0)
Atopic comorbidity, n (%)	6 (50)	3 (37.5)
Allergic rhinitis	2 (16.7)	1 (12.5)
Asthma	1 (8.3)	0 (0)
Atopic dermatitis	4 (33.3)	3 (37.5)
Food allergies	2 (16.7)	1 (12.5)
Eosinophilic esophagitis comorbidity, n (%)	12 (100)	8 (100)
Eosinophilic gastritis and duodenitis, n (%)	2 (16.7)	2 (25)
Eosinophilic gastritis without duodenitis, n (%)	3 (25)	2 (25)
Eosinophilic duodenitis, without gastritis, n (%)	7 (58.3)	4 (50)